E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/19/2017 in the Prospect News Structured Products Daily.

New Issue: Morgan Stanley sells $3.23 million contingent income autocalls on ETFs

New York, July 19 – Morgan Stanley Finance LLC priced $3.22 million of contingent income autocallable securities due July 17, 2020 linked to the worse performing of the Financial Select Sector SPDR fund and the SPDR S&P Biotech exchange-traded fund, according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annual rate of 8.5% if each ETF closes at or above its 60% downside threshold on the determination date that quarter.

The notes will be called at par plus the contingent coupon if each ETF closes at or above its initial level on any quarterly determination date other than the final determination date.

The payout at maturity will be par plus the contingent coupon unless either ETF finishes below its 60% downside threshold, in which case investors will lose 1% for each 1% decline of the lesser performing ETF.

The notes are guaranteed by Morgan Stanley.

Morgan Stanley & Co. LLC is the agent.

Issuer:Morgan Stanley Finance LLC
Guarantor:Morgan Stanley
Issue:Contingent income autocallable securities
Underlying ETFs: Financial Select Sector SPDR fund and the SPDR S&P Biotech exchange-traded fund
Amount:$3,225,000
Maturity:July 17, 2020
Coupon:8.5% annualized for each quarter that each ETF closes at or above downside threshold on observation date for quarter
Price:Par
Payout at maturity:Par plus contingent coupon if each ETF finishes at or above downside threshold; otherwise, 1% loss for each 1% decline of worst performing ETF
Call:At par plus contingent payment if each ETF closes at or above initial level on any quarterly determination date other than the final determination date
Initial levels:$24.92 for Financial Select, $79.07 for S&P Biotech
Downside thresholds:$14.952 for Financial Select, $47.442 for S&P Biotech; 60% of initial levels
Pricing date:July 14
Settlement date:July 19
Agent:Morgan Stanley & Co. LLC
Fees:2%
Cusip:61768CMH7

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.